Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer

Immunotherapy for skin malignancies has ushered in a new era for cancer treatments by demonstrating unprecedented durable responses in the setting of metastatic Melanoma. Consequently, checkpoint inhibitors are now the first-line treatment of metastatic melanoma and widely used as adjuvant therapy f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bridge, Jennifer A., Lee, James C., Daud, Adil, Wells, James W., Bluestone, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315146/
https://www.ncbi.nlm.nih.gov/pubmed/30631766
http://dx.doi.org/10.3389/fmed.2018.00351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315146/
https://www.ncbi.nlm.nih.gov/pubmed/30631766
http://dx.doi.org/10.3389/fmed.2018.00351

Ejemplares similares